Research Article

Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN)

Table 3

Physical performance, health-related quality of life, and functional outcome.

SARS-CoV-2 n = 206Control n = 206Difference in means/odds ratioMissing values, SARS-CoV-2/control

6-minute walk-test results
 Walk distance (meters)590.8 ± 77.7600.8 ± 92.4−10.4 [26.6; 6.5]0/3
 Walk distance ratio (0-1)0.97 ± 0.170.98 ± 0.16−0.01 [0.04; 0.02]4/3

Borg scales
 Borg CR scale (0-10) at rest0.05 ± 0.240.01 ± 0.080.04 [0.01; 0.09]0/1
 Borg CR scale (0-10) after stress0.8 ± 1.230.41 ± 0.910.39 [0.19; 0.59]0/1
 Borg rating of perceived exertion (6-20)9.6 ± 2.98.7 ± 2.60.8 [0.3; 1.4]0/1

EQ-5D-5L (European quality of life 5-dimension-5-level)
 VAS-index-score (%)83.6±15.288.6 ± 12.4−4.9 [7.6; −2.3]0/0
 Calculated index-score (0-1)0.92±0.120.95 ± 0.1−0.03 [0.05; −0.01]0/1

SF-36 (short form 36) scores
 Physical functioning score (0–100)88.0±15.393.6 ± 10.9−5.6 [8.2; −2.9]11/2
 Role functioning/physical score (0–100)76.0±33.992.0 ± 22.7−16.0 [21.6; −10.4]1/0
 Role functioning/emotional score (0–100)73.6±37.888.0 ± 27.0−14.4 [20.8; −7.9]10/3
 Energy/fatigue score (0–100)56.8±23.0467.9 ± 21.5−11.0 [15.4; −6.7]1/0
 Emotional well-being score (0–100)72.8±17.681.1 ± 15.2−8.2 [11.4; −5.0]1/0
 Social functioning score (0–100)83.7±22.590.7 ± 17.6−7.0 [11.0; −3.1]8/2
 Pain score (0–100)84.9±22.190.7 ± 17.2−5.9 [9.7; −2.0]9/2
 General health score (0–100)72.8±21.080.1 ± 16.9−7.3 [11.0; −3.6]0/0

PCFS (post-COVID-19 functional status)
 PCFS 2/3 (no. (%)63 (30.6)30 (14.5)OR 2.6 [1.6; 4.2]0/0

Data are given as mean ± standard deviation, and in square brackets, 95% confidence interval is given; significant differences in means/odds ratios are written in bold type.